Molecure S.A. (MOC.WA)

PLN 8.5

(0.0%)

Long Term Debt Summary of Molecure S.A.

Molecure S.A.'s latest annual long term debt in 2023 was 4.97 Million PLN , up 18.4% from previous year.
Molecure S.A.'s latest quarterly long term debt in 2024 Q3 was - PLN , down 0.0% from previous quarter.
Molecure S.A. reported annual long term debt of 4.2 Million PLN in 2022, up 0.09% from previous year.
Molecure S.A. reported annual long term debt of 4.19 Million PLN in 2021, up 23.28% from previous year.
Molecure S.A. reported quarterly long term debt of 3.94 Million PLN for 2024 Q2, down 0.0% from previous quarter.
Molecure S.A. reported quarterly long term debt of - PLN for 2024 Q3, down 0.0% from previous quarter.

Annual Long Term Debt Chart of Molecure S.A. (2023 - 2014)

Historical Annual Long Term Debt of Molecure S.A. (2023 - 2014)

Year	Long Term Debt	Long Term Debt Growth
2023	4.97 Million PLN	18.4%
2022	4.2 Million PLN	0.09%
2021	4.19 Million PLN	23.28%
2020	3.4 Million PLN	35.76%
2019	2.5 Million PLN	0.0%
2018	- PLN	0.0%
2017	- PLN	0.0%
2016	- PLN	0.0%
2015	- PLN	0.0%
2014	- PLN	0.0%

Year	Long Term Debt	Long Term Debt Growth
2024 Q1	4.97 Million PLN	0.0%
2024 Q2	3.94 Million PLN	0.0%
2024 Q3	- PLN	0.0%
2023 Q2	3.32 Million PLN	-21.0%
2023 Q3	3.32 Million PLN	0.0%
2023 Q4	4.97 Million PLN	49.86%
2023 FY	4.97 Million PLN	18.4%
2023 Q1	4.2 Million PLN	0.0%
2022 Q3	4 Million PLN	15.43%
2022 Q2	3.47 Million PLN	-17.33%
2022 FY	4.2 Million PLN	0.09%
2022 Q1	4.19 Million PLN	0.0%
2022 Q4	4.2 Million PLN	4.89%
2021 Q4	4.19 Million PLN	-25.62%
2021 Q3	5.64 Million PLN	0.0%
2021 Q2	5.64 Million PLN	65.74%
2021 FY	4.19 Million PLN	23.28%
2021 Q1	3.4 Million PLN	0.0%
2020 Q1	2.5 Million PLN	0.0%
2020 Q2	2.5 Million PLN	0.0%
2020 FY	3.4 Million PLN	35.76%
2020 Q4	3.4 Million PLN	35.76%
2020 Q3	2.5 Million PLN	0.0%
2019 Q4	2.5 Million PLN	14.12%
2019 FY	2.5 Million PLN	0.0%
2019 Q3	2.19 Million PLN	0.0%
2019 Q2	2.19 Million PLN	3.05%
2019 Q1	2.13 Million PLN	0.0%
2018 Q4	- PLN	0.0%
2018 FY	- PLN	0.0%
2018 Q1	- PLN	0.0%
2018 Q2	- PLN	0.0%
2018 Q3	- PLN	0.0%
2017 Q2	- PLN	0.0%
2017 FY	- PLN	0.0%
2017 Q3	- PLN	0.0%
2017 Q4	- PLN	0.0%
2017 Q1	- PLN	0.0%
2016 Q4	- PLN	0.0%
2016 FY	- PLN	0.0%
2016 Q1	- PLN	0.0%
2015 FY	- PLN	0.0%
2014 FY	- PLN	0.0%

Peer Long Term Debt Comparison of Molecure S.A.

Name	Long Term Debt	Long Term Debt Difference
Bioceltix S.A.	76.33 Thousand PLN	-6418.571%
BIOTON S.A.	12.67 Million PLN	60.749%
Captor Therapeutics Spolka Akcyjna	1.24 Million PLN	-299.023%
Mabion S.A.	2.94 Million PLN	-68.786%
NanoGroup S.A.	- PLN	-Infinity%
Pharmena S.A.	114 Thousand PLN	-4264.755%
Poltreg S.A.	7.8 Million PLN	36.216%
Pure Biologics Spólka Akcyjna	12.85 Million PLN	61.284%
Ryvu Therapeutics S.A.	365 Thousand PLN	-1263.239%
Synthaverse S.A.	61.2 Million PLN	91.87%
Urteste S.A.	312 Thousand PLN	-1494.814%